Bioimmuno Labs Private Limited - Company Profile

It is a healthcare private limited company based in Kolkata, West Bengal, India, established in 2018.
2018 Kolkata, West Bengal, India Active
Last Updated:
Access Report
About Bioimmuno Labs Private Limited

Bioimmuno Labs Private Limited, a active private limited company, was established on 25 May 2018 in Kolkata, West Bengal, India. Engaging in diagnostic centers & pathology labs within the hospital and medical care sector, it holds CIN: U85300WB2018PTC226287. Registered under ROC Roc Kolkata. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.

Its leadership includes Manash Dey (Director), Papri Dey (Director). Past directors included Jayanta Chowdhury. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 29/2, S.M. Ali Road Barrackpore, Kolkata, West Bengal, 700120.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85300WB2018PTC226287

  • Registration Number

    226287

  • Incorporation Date

    25 May 2018

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹1.00 M

  • ROC Code

    Roc Kolkata

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 1.00 M
  • Company Age 7 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 42.96%
  • Profit Growth **** -48.31%
  • Ebitda **** -8.05%
  • Net Worth 1.32%
  • Total Assets **** 24.69%
Company report

Bioimmuno Labs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Bioimmuno Labs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Bioimmuno Labs Private Limited?
Current Directors
Name Designation Appointment Date Status
Manash Dey Director 25 May 2018 Current
Papri Dey Director 05 Feb 2019 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Feb 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Bioimmuno Labs.

Bioimmuno Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.96% increase. The company also saw a substantial fall in profitability, with a 48.31% decrease in profit. The company's net worth moved up by a moderate rise of 1.32%.

Bioimmuno Labs revenue growth over time
Bioimmuno Labs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 42.96%
*******
*******
*******
*******
Revenue from Operations
*******
 42.96%
*******
*******
*******
*******
Total Assets
*******
 24.69%
*******
*******
*******
*******
Profit or Loss
*******
 -48.31%
*******
*******
*******
*******
Net Worth
*******
 1.32%
*******
*******
*******
*******
EBITDA
*******
 -8.05%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Bioimmuno Labs?

In 2020, Bioimmuno Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Bioimmuno Labs?

Unlock and access historical data on people associated with Bioimmuno Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Bioimmuno Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bioimmuno Labs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Bioimmuno Labs
Recent Activity within the Organization
  • Annual General Meeting

    The activity Bioimmuno Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Bioimmuno Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata. was documented.

  • Director Appointment

    The activity Papri Dey was appointed as a Director was appointed as a Director on 05 Feb 2019 & has been associated with this company since 7 years 10 days . was completed.

  • Director Appointment

    The activity Manash Dey was appointed as a Director was appointed as a Director on 25 May 2018 & has been associated with this company since 7 years 8 months . was completed.

  • Company Incorporation

    Bioimmuno Labs Private Limited was registered on 25 May 2018 with Roc Kolkata & aged 7 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Bioimmuno Labs Private Limited?

The CIN of Bioimmuno Labs Private Limited is U85300WB2018PTC226287.

Where is Bioimmuno Labs Private Limited headquartered?

Bioimmuno Labs Private Limited is headquartered at 29/2, S.M. Ali Road Barrackpore, Kolkata, West Bengal, 700120.

When was Bioimmuno Labs Private Limited incorporated?

Bioimmuno Labs Private Limited was incorporated on 25 May 2018.

Who are the current directors of Bioimmuno Labs Private Limited?

The current directors of Bioimmuno Labs Private Limited are

What is the primary industry of Bioimmuno Labs Private Limited?

The primary industry of Bioimmuno Labs Private Limited is Hospital And Medical Care.

Is Bioimmuno Labs Private Limited a listed company?

Bioimmuno Labs Private Limited is unlisted.

What is the capital structure of Bioimmuno Labs Private Limited?

The authorized capital of Bioimmuno Labs Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available